Rehabilitation of the cancer patient

DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology: Tenth Edition

Volumn , Issue , 2015, Pages

  Stubblefield, Michael D ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84976582466     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (217)

1. Stubblefield MD, O'Dell MW. Cancer Rehabilitation Principles and Practice. New York: Demos Medical Publishers; 2009.
2. Cancer Facts & Figures 2013. American Cancer Society Web site. http://www.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2013. Accessed on (date).
3. Mariotto AB, Yabroff KR, Shao Y, et al. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011;103:117-128.
4. National Spinal Cord Injury Statistical Center. Spinal cord injury facts and figures at a glance. J Spinal Cord Med 2013; 36:394-395.
5. PM&R Programs. Fellowship Programs. Association of Academic Physiatrists Web site. http://www.physiatry.org/?page=fellowship_programs. Accessed on (date).
6. Sharp L, Vernino S. Paraneoplastic neuromuscular disorders. Muscle Nerve 2012;46:841-850.
7. Gullett N, Rossi P, Kucuk O, et al. Cancer-induced cachexia: a guide for the oncologist. J Soc Integr Oncol 2009;7:155-169.
8. Lumachi F, Brunello A, Roma A, et al. Cancer-induced hypercalcemia. Anticancer Res 2009;29:1551-1555.
9. Bertagna X, Guignat L, Groussin L, et al. Cushing's disease. Best Pract Res Clin Endocrinol Metab 2009;23:607-623.
10. Varki A. Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood 2007;110:1723-1729.
11. Toothaker TB, Rubin M. Paraneoplastic neurological syndromes: a review. Neurologist 2009;15:21-33.
12. Hauer-Jensen M, Fink LM, Wang J. Radiation injury and the protein C pathway. Crit Care Med 2004;32:S325-S330.
13. Stubblefield MD. Radiation fibrosis syndrome: neuromuscular and musculoskeletal complications in cancer survivors. PM R 2011;3:1041-1054.
14. Clinical Practice Guidelines in Oncology. Venous thromboembolic disease V.1.2010. National Comprehensive Cancer Network Web site. http://www.nccn.org. Accessed on (date).
15. Kelly BM, Yoder BM, Tang CT, et al. Venous thromboembolic events in the rehabilitation setting. PM R 2010;2:647-663.
16. Partsch H. Bed rest versus ambulation in the initial treatment of patients with proximal deep vein thrombosis. Curr Opin Pulmonary Med 2002;8:389-393.
17. Kiser TS, Stefans VA. Pulmonary embolism in rehabilitation patients: relation to time before return to physical therapy after diagnosis of deep vein thrombosis. Arch Phys Med Rehabil 1997;78:942-945.
18. Koopman MM, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med 1996;334:682-687.
19. Levine M, Gent M, Hirsh J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334:677-681.
20. Partsch H, Kechavarz B, Kohn H, et al. The effect of mobilisation of patients during treatment of thromboembolic disorders with low-molecular-weight heparin. Int Angiol 1997;16:189-192.
21. Schellong SM, Schwarz T, Kropp J, et al. Bed rest in deep vein thrombosis and the incidence of scintigraphic pulmonary embolism. Thromb Haemost 1999;82:127-129.
22. Partsch H, Blattler W. Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin. J Vasc Surg 2000;32:861-869.
23. Aschwanden M, Labs KH, Engel H, et al. Acute deep vein thrombosis: early mobilization does not increase the frequency of pulmonary embolism. Thromb Haemost 2001;85:42-46.
24. Partsch H. Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation. Vasa 2001;30:195-204.
25. Junger M, Diehm C, Storiko H, et al. Mobilization versus immobilization in the treatment of acute proximal deep venous thrombosis: a prospective, randomized, open, multicentre trial. Curr Med Res Opin 2006;22:593-602.
26. Aldrich D, Hunt DP. When can the patient with deep venous thrombosis begin to ambulate? Phys Ther 2004;84:268-273.
27. Partsch H. Immediate ambulation and leg compression in the treatment of deep vein thrombosis. Dis Mon 2005;51:135-140.
28. Partsch H. Ambulation and compression after deep vein thrombosis: dispelling myths. Semin Vasc Surg 2005;18:148-152.
29. Kahn SR, Shrier I, Kearon C. Physical activity in patients with deep venous thrombosis: a systematic review. Thromb Res 2008;122:763-773.
30. Gay V, Hamilton R, Heiskell S, et al. Influence of bedrest or ambulation in the clinical treatment of acute deep vein thrombosis on patient outcomes: a review and synthesis of the literature. Medsurg Nurs 2009;18:293-299.
31. Aissaoui N, Martins E, Mouly S, et al. A meta-analysis of bed rest versus early ambulation in the management of pulmonary embolism, deep vein thrombosis, or both. Int J Cardiol 2009;137:37-41.
32. Joffe HV, Kucher N, Tapson VF, et al. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation 2004;110:1605-1611.
33. Joffe HV, Goldhaber SZ. Upper-extremity deep vein thrombosis. Circulation 2002;106:1874-1880.
34. Custodio CM. Neuromuscular complications of cancer and cancer treatments. Phys Med Rehabil Clin N Am 2008;19:27-45.
35. Greenberg E, Treger I, Ring H. Rehabilitation outcomes in patients with brain tumors and acute stroke Comparative study of inpatient rehabilitation. Am J Phys Med Rehab 2006;85:568-573.
36. O'Dell MW, Barr K, Spanier D, et al. Functional outcome of inpatient rehabilitation in persons with brain tumors. Arch Phys Med Rehab 1998;79:1530-1534.
37. Mukand JA, Blackinton DD, Crincoli MG, et al. Incidence of neurologic deficits and rehabilitation sd patients with brain tumors. Am J Phys Med Rehab 2001;80:346-350.
38. Geler-Kulcu D, Gulsen G, Buyukbaba E, et al. Functional recovery of patients with brain tumor or acute stroke after rehabilitation: A comparative study. J Clin Neurosci 2009;16:74-78.
39. Huang ME, Wartella JE, Kreutzer JS. Functional outcomes and quality of life in patients with brain tumors: A preliminary report. Arch Phys Med Rehab 2001;82:1540-1546.
40. Kirshblum S, O'Dell MW, Ho C, et al. Rehabilitation of persons with central nervous system tumors. Cancer 2001;92:1029-1038.
41. Parsch D, Mikut R, Abel R. Postacute management of patients with spinal cord injury due to metastatic tumour disease: survival and efficacy of rehabilitation. Spinal Cord 2003;41:205-210.
42. Stubblefield MD, Bilsky MH. Barriers to rehabilitation of the neurosurgical spine cancer patient. J Surg Oncol 2007;95:419-426.
43. Wang JC, Boland P, Mitra N, et al. Single-stage posterolateral transpedicular approach for resection of epidural metastatic spine tumors involving the vertebral body with circumferential reconstruction: results in 140 patients. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J Neurosurg Spine 2004;1:287-298.
44. Guo Y, Young B, Palmer JL, et al. Prognostic factors for survival in metastatic spinal cord compression: a retrospective study in a rehabilitation setting. Am J Phys Med Rehabil 2003;82:665-668.
45. Ecker RD, Endo T, Wetjen NM, Krauss WE. Diagnosis and treatment of vertebral column metastases. Mayo Clin Proc 2005;80:1177-1186.
46. DeAngelis LM, Boutros D. Leptomeningeal metastasis. Cancer Invest 2005;23:145-154.
47. Wuermser LA, Ho CH, Chiodo AE, et al. Spinal cord injury medicine. 2. Acute care management of traumatic and nontraumatic injury. Arch Phys Med Rehabil 2007;88:S55-S61.
48. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:338S-400S.
49. McKinley WO, Conti-Wyneken AR, Vokac CW, et al. Rehabilitative functional outcome of patients with neoplastic spinal cord compressions. Arch Phys Med Rehabil 1996;77:892-895.
50. New PW, Rawicki HB, Bailey MJ. Nontraumatic spinal cord injury: demographic characteristics and complications. Arch Phys Med Rehabil 2002;83:996-1001.
51. Tarulli AW, Raynor EM. Lumbosacral radiculopathy. Neurol Clin 2007;25:387-405.
52. Radhakrishnan K, Litchy WJ, O'Fallon WM, et al. Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990. Brain 1994;117:325-335.
53. Ciol MA, Deyo RA, Howell E, et al. An assessment of surgery for spinal stenosis: Time trends, geographic variations, complications, and reoperations. J Am Geriatr Soc 1996;44:285-290.
54. Posner JB. Neurologic Complications of Cancer. Philadelphia: F.A. Davis Company; 1995.
55. Chamberlain MC. Neurotoxicity of cancer treatment. Curr Oncol Rep 2010;12:60-67.
56. Gilden D, Cohrs RJ, Mahalingam R, et al. Neurological disease produced by Varicella zoster virus reactivation without rash. Curr Top Microbiol Immunol 2010;342:243-253.
57. Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007;44:S1-S26.
58. Hsia AW, Katz JS, Hancock SL, et al. Post-irradiation polyradiculopathy mimics leptomeningeal tumor on MRI. Neurology 2003;60:1694-1696.
59. Greenfield MM, Stark FM. Post-irradiation neuropathy. Am J Roentgenol Radium Ther 1948;60:617-622.
60. Maier JG, Perry RH, Saylor W, et al. Radiation myelitis of the dorsolumbar spinal cord. Radiology 1969;93:153-160.
61. Kristensen O, Melgard B, Schiodt AV. Radiation myelopathy of the lumbo-sacral spinal cord. Acta Neurol Scand 1977;56:217-222.
62. Berlit P, Schwechheimer K. Neuropathological findings in radiation myelopathy of the lumbosacral cord. Eur Neurol 1987;27:29-34.
63. Lamy C, Mas JL, Varet B, et al. Postradiation lower motor neuron syndrome presenting as monomelic amyotrophy. J Neurol Neurosurg Psychiatry 1991;54:648-649.
64. Bowen J, Gregory R, Squier M, et al. The post-irradiation lower motor neuron syndrome neuronopathy or radiculopathy? Brain 1996;119:1429-1439.
65. Stubblefield MD, Slovin S, MacGregor-Cortelli B, et al. An electrodiagnostic evaluation of the effect of pre-existing peripheral nervous system disorders in patients treated with the novel proteasome inhibitor bortezomib. Clin Oncol (R Coll Radiol) 2006;18:410-418.
66. Stubblefield MD, McNeely ML, Alfano CM, et al. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy. Cancer 2012;118:2250-2260.
67. Dropcho EJ. Remote neurologic manifestations of cancer. Neurol Clin 2002;20:85-122.
68. Jaeckle KA. Neurological manifestations of neoplastic and radiation-induced plexopathies. Semin Neurol 2004;24:385-393.
69. Pourmand R. Neuromuscular Diseases: Expert Clinicians' Views. Boston: Butterworth-Heinemann; 2001.
70. Lusk MD, Kline DG, Garcia CA. Tumors of the brachial plexus. Neurosurgery 1987;21:439-453.
71. Donner TR, Voorhies RM, Kline DG. Neural sheath tumors of major nerves. J Neurosurg 1994;81:362-373.
72. Ganju A, Roosen N, Kline DG, et al. Outcomes in a consecutive series of 111 surgically treated plexal tumors: a review of the experience at the Louisiana State University Health Sciences Center. J Neurosurg 2001;95:51-60.
73. Dropcho EJ. Neurotoxicity of radiation therapy. Neurol Clin 2010;28:217-234.
74. Galecki J, Hicer-Grzenkowicz J, Grudzien-Kowalska M, et al. Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer-a review. Acta Oncol 2006;45:280-284.
75. Kori SH, Foley KM, Posner JB. Brachial plexus lesions in patients with cancer: 100 cases. Neurology 1981;31:45-50.
76. Sureka J, Cherian RA, Alexander M, et al. MRI of brachial plexopathies. Clin Radiol 2009;64:208-218.
77. Thomas JE, Colby MY Jr. Radiation-induced or metastatic brachial plexopathy? A diagnostic dilemma. JAMA 1972;222:1392-1395.
78. Ferrante MA. Brachial plexopathies: classification, causes, and consequences. Muscle Nerve 2004;30:547-568.
79. Sathasivam S, Lecky B, Manohar R, et al. Neuralgic amyotrophy. J Bone Joint Surg Br 2008;90:550-553.
80. Tracy JA, Dyck PJ. The spectrum of diabetic neuropathies. Phys Med Rehabil Clin N Am 2008;19:1-26.
81. Stubblefield MD, Burstein HJ, Burton AW, et al. NCCN task force report: management of neuropathy in cancer. J Natl Compr Canc Netw 2009;7:S1-S26.
82. Vallat JM, Sommer C, Magy L. Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition. Lancet Neurol 2010;9:402-412.
83. Lee JJ, Swain SM. Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol 2006;24:1633-1642.
84. Umapathi T, Chaudhry V. Toxic neuropathy. Curr Opin Neurol 2005;18:574-580.
85. Kocer B, Sucak G, Kuruoglu R, et al. Clinical and electrophysiological evaluation of patients with thalidomide-induced neuropathy. Acta Neurol Belg 2009;109:120-126.
86. Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol 2002;249:9-17.
87. Lauria G, Pareyson D, Sghirlanzoni A. Neurophysiological diagnosis of acquired sensory ganglionopathies. Eur Neurol 2003;50:146-152.
88. Ramchandren S, Lewis RA. Monoclonal gammopathy and neuropathy. Curr Opin Neurol 2009;22:480-485.
89. Portlock CS, Boland P, Hays AP, et al. Nemaline myopathy: a possible late complication of Hodgkin's disease therapy. Hum Pathol 2003;34:816-818.
90. Tuoheti Y, Okada K, Osanai T, et al. Skeletal muscle metastases of carcinoma: a clinicopathological study of 12 cases. Jpn J Clin Oncol 2004;34:210-214.
91. Levin MI, Mozaffar T, Al-Lozi MT, et al. Paraneoplastic necrotizing myopathy: clinical and pathological features. Neurology 1998;50:764-767.
92. Briani C, Doria A, Sarzi-Puttini P, et al. Update on idiopathic inflammatory myopathies. Autoimmunity 2006;39:161-170.
93. Smestad C, Monstad P, Lindboe CF, et al. Amyloid myopathy presenting with distal atrophic weakness. Muscle Nerve 2004;29:605-609.
94. Friedman Y, Paul JT, Turley J, et al. Axial myopathy due to primary amyloidosis. Muscle Nerve 2007;36:542-546.
95. Walsh RJ, Amato AA. Toxic myopathies. Neurol Clin 2005;23:397-428.
96. Schakman O, Gilson H, Thissen JP. Mechanisms of glucocorticoid-induced myopathy. J Endocrinol 2008;197:1-10.
97. Owczarek J, Jasinska M, Orszulak-Michalak D. Drug-induced myopathies. An overview of the possible mechanisms. Pharmacol Rep 2005;57:23-34.
98. Batchelor TT, Taylor LP, Thaler HT, et al. Steroid myopathy in cancer patients. Neurology 1997;48:1234-1238.
99. Hund E. Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol 2001;248:929-934.
100. Stoll G, Bendszus M, Perez J, et al. Magnetic resonance imaging of the peripheral nervous system. J Neurol 2009;256:1043-1051.
101. van Es HW, Bollen TL, van Heesewijk HP. MRI of the brachial plexus: A pictorial review. Eur J Radiol 2010;74:391-402.
102. Huang JH, Johnson VE, Zager EL. Tumors of the peripheral nerves and plexuses. Curr Treat Options Neurol 2006;8:299-308.
103. England JD, Gronseth GS, Franklin G, et al. Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve 2009;39:116-125.
104. Stubblefield MD, Custodio CM. Upper-extremity pain disorders in breast cancer. Arch Phys Med Rehabil 2006;87:S96-S99.
105. Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer 1987;55:61-66.
106. Griessmann H, Schuttemeyer W. Weitere Erfahrungen mit der Marknagelung nach Kuntscher an der Chirurgische Universitatsklinik Kiel. Chirug 1947;17/18:316-333.
107. Bunting RW, Shea B. Bone metastasis and rehabilitation. Cancer 2001;92:1020-1028.
108. Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res 1989:256-264.
109. Van der Linden YM, Dijkstra PD, Kroon HM, et al. Comparative analysis of risk factors for pathological fracture with femoral metastases. J Bone Joint Surg Br 2004;86:566-573.
110. Vargo M. Orthopedic management of malignant bone lesions. PM&R State Art Rev 1994;8:363-391.
111. Fisher CG, DiPaola CP, Ryken TC, et al. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila Pa 1976) 2010;35:E1221-E1229.
112. Fourney DR, Frangou EM, Ryken TC, et al. Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group. J Clin Oncol 2011;29:3072-3077.
113. Bilsky MH. New therapeutics in spine metastases. Expert Rev Neurother 2005;5:831-840.
114. Laufer I, Rubin DG, Lis E, et al. The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist 2013;18:744-751.
115. Yarnold J, Brotons MC. Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol 2010;97:149-161.
116. Libshitz HI, DuBrow RA, Loyer EM, et al. Radiation change in normal organs: an overview of body imaging. Eur Radiol 1996;6:786-795.
117. New P. Radiation injury to the nervous system. Curr Opin Neurol 2001;14:725-734.
118. Johansson S, Svensson H, Denekamp J. Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients. Int J Radiat Oncol Biol Phys 2002;52:1207-1219.
119. Stone HB, Coleman CN, Anscher MS, et al. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 2003;4:529-536.
120. Falkmer U, Jarhult J, Wersall P, et al. A systematic overview of radiation therapy effects in skeletal metastases. Acta Oncol 2003;42:620-633.
121. Thompson CA, Mauck K, Havyer R, et al. Care of the adult Hodgkin lymphoma survivor. Am J Med 2011;124:1106-1112.
122. Cross NE, Glantz MJ. Neurologic complications of radiation therapy. Neurol Clin 2003;21:249-277.
123. Pradat PF, Delanian S. Late radiation injury to peripheral nerves. Handb Clin Neurol 2013;115:743-758.
124. Miller TM, Layzer RB. Muscle cramps. Muscle Nerve 2005;32:431-442.
125. Gutmann L, Gutmann L. Myokymia and neuromyotonia 2004. J Neurol 2004;251:138-142.
126. Baxi SS, Matasar MJ. State-of-the-art issues in Hodgkin's lymphoma survivorship. Curr Oncol Rep 2010;12:366-373.
127. Jaeckle KA. Neurologic manifestations of neoplastic and radiation-induced plexopathies. Semin Neurol 2010;30:254-262.
128. Herrera JE, Stubblefield MD. Rotator cuff tendonitis in lymphedema: a retrospective case series. Arch Phys Med Rehabil 2004;85:1939-1942.
129. Dijkstra PU, van Wilgen PC, Buijs RP, et al. Incidence of shoulder pain after neck dissection: a clinical explorative study for risk factors. Head Neck 2001;23:947-953.
130. Robbins KT, Clayman G, Levine PA, et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 2002;128:751-758.
131. Speksnijder CM, van der Bilt A, Slappendel M, et al. Neck and shoulder function in patients treated for oral malignancies: a 1-year prospective cohort study. Head Neck 2013;35:1303-1313.
132. McNeely ML, Parliament M, Courneya KS, et al. A pilot study of a randomized controlled trial to evaluate the effects of progressive resistance exercise training on shoulder dysfunction caused by spinal accessory neurapraxia/neurectomy in head and neck cancer survivors. Head Neck 2004;26:518-530.
133. McNeely ML, Parliament MB, Seikaly H, et al. Effect of exercise on upper extremity pain and dysfunction in head and neck cancer survivors: a randomized controlled trial. Cancer 2008;113:214-222.
134. Lauchlan DT, McCaul JA, McCarron T, et al. An exploratory trial of preventative rehabilitation on shoulder disability and quality of life in patients following neck dissection surgery. Eur J Cancer Care (Engl) 2011;20:113-122.
135. Carvalho AP, Vital FM, Soares BG. Exercise interventions for shoulder dysfunction in patients treated for head and neck cancer. Cochrane Database Syst Rev 2012;4:CD008693.
136. Dijkstra PU, Kalk WW, Roodenburg JL. Trismus in head and neck oncology: a systematic review. Oral Oncol 2004;40:879-889.
137. Tveteras K, Kristensen S. The aetiology and pathogenesis of trismus. Clin Otolaryngol Allied Sci 1986;11:383-387.
138. Dijkstra PU, Huisman PM, Roodenburg JL. Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg 2006;35:337-342.
139. Ichimura K, Tanaka T. Trismus in patients with malignant tumours in the head and neck. J Laryngol Otol 1993;107:1017-1020.
140. Louise Kent M, Brennan MT, Noll JL, et al. Radiation-induced trismus in head and neck cancer patients. Support Care Cancer 2008;16:305-309.
141. Wang CJ, Huang EY, Hsu HC, et al. The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer. Laryngoscope 2005;115:1458-1460.
142. Teguh DN, Levendag PC, Voet P, et al. Trismus in patients with oropharyngeal cancer: relationship with dose in structures of mastication apparatus. Head Neck 2008;30:622-630.
143. Goldstein M, Maxymiw WG, Cummings BJ, et al. The effects of antitumor irradiation on mandibular opening and mobility: a prospective study of 58 patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:365-373.
144. Dhanrajani PJ, Jonaidel O. Trismus: aetiology, differential diagnosis and treatment. Dent Update 2002;29:88-92.
145. Dijkstra PU, Sterken MW, Pater R, et al. Exercise therapy for trismus in head and neck cancer. Oral Oncol 2007;43:389-394.
146. Grandi G, Silva ML, Streit C, et al. A mobilization regimen to prevent mandibular hypomobility in irradiated patients: an analysis and comparison of two techniques. Med Oral Patol Oral Cir Bucal 2007;12:E105-E109.
147. Buchbinder D, Currivan RB, Kaplan AJ, et al. Mobilization regimens for the prevention of jaw hypomobility in the radiated patient: a comparison of three techniques. J Oral Maxillofac Surg 1993;51:863-867.
148. Tang Y, Shen Q, Wang Y, et al. A randomized prospective study of rehabilitation therapy in the treatment of radiation-induced dysphagia and trismus. Strahlenther Onkol 2011;187:39-44.
149. King GE, Scheetz J, Jacob RF, et al. Electrotherapy and hyperbaric oxygen: promising treatments for postradiation complications. J Prosthet Dent 1989;62:331-334.
150. Chua DT, Lo C, Yuen J, et al. A pilot study of pentoxifylline in the treatment of radiation-induced trismus. Am J Clin Oncol 2001;24:366-369.
151. Bhrany AD, Izzard M, Wood AJ, Futran ND. Coronoidectomy for the treatment of trismus in head and neck cancer patients. Laryngoscope 2007;117:1952-1956.
152. Stubblefield MD, Levine A, Custodio CM, et al. The role of botulinum toxin type A in the radiation fibrosis syndrome: a preliminary report. Arch Phys Med Rehabil 2008;89:417-421.
153. Hartl DM, Cohen M, Julieron M, et al. Botulinum toxin for radiation-induced facial pain and trismus. Otolaryngol Head Neck Surg 2008;138:459-463.
154. Cousins N, MacAulay F, Lang H, et al. A systematic review of interventions for eating and drinking problems following treatment for head and neck cancer suggests a need to look beyond swallowing and trismus. Oral Oncol 2013;49:387-400.
155. Cohen EG, Deschler DG, Walsh K, et al. Early use of a mechanical stretching device to improve mandibular mobility after composite resection: a pilot study. Arch Phys Med Rehabil 2005;86:1416-1419.
156. Kamstra JI, Roodenburg JL, Beurskens CH, et al. TheraBite exercises to treat trismus secondary to head and neck cancer. Support Care Cancer 2013;21:951-957.
157. Lubit EC. The trismus exerciser. An oral dynamic bite opener. N Y State Dent J 1968;34:489-493.
158. Brown KE. Dynamic opening device for mandibular trismus. J Prosthet Dent 1968;20:438-442.
159. Kouyoumdjian JH, Chalian VA, Hutton C. An intraoral positive-pressure device for treatment of trismus. Oral Surg Oral Med Oral Pathol 1986;61:456-458.
160. Dijkstra PU, Kropmans TJ, Tamminga RY. Modified use of a dynamic bite opener-treatment and prevention of trismus in a child with head and neck cancer: a case report. Cranio 1992;10:327-329.
161. Brunello DL, Mandikos MN. The use of a dynamic opening device in the treatment of radiation induced trismus. Aust Prosthodont J 1995;9:45-48.
162. Lo LJ, Lin CL, Chen YR. A device for temporomandibular joint exercise and trismus correction: design and clinical application. J Plast Reconstr Aesthet Surg 2008;61:297-301.
163. Shulman DH, Shipman B, Willis FB. Treating trismus with dynamic splinting: a cohort, case series. Adv Ther 2008;25:9-16.
164. Stubblefield MD, Manfield L, Riedel ER. A preliminary report on the efficacy of a dynamic jaw opening device (dynasplint trismus system) as part of the multimodal treatment of trismus in patients with head and neck cancer. Arch Phys Med Rehabil 2010;91:1278-1282.
165. Usuba M, Akai M, Shirasaki Y, et al. Experimental joint contracture correction with low torque-long duration repeated stretching. Clin Orthop Relat Res 2007;456:70-78.
166. Astudillo L, Hollington L, Game X, et al. Cervical dystonia mimicking dropped-head syndrome after radiotherapy for laryngeal carcinoma. Clin Neurol Neurosurg 2003;106:41-43.
167. Costa J, Espirito-Santo C, Borges A, et al. Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev 2005:CD003633.
168. DiSipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 2013;14:500-515.
169. Shah C, Arthur D, Riutta J, et al. Breast-cancer related lymphedema: a review of procedure-specific incidence rates, clinical assessment AIDS, treatment paradigms, and risk reduction. Breast J 2012;18:357-361.
170. Braddom RL, ed. Physical Medicine and Rehabilitation. 3rd ed. Philadelphia: WB Saunders Company; 2007.
171. Sadeghi R, Kazemzadeh G, Keshtgar M. Diagnostic application of lymphoscintigraphy in the management of lymphoedema. Hell J Nucl Med 2010;13:6-10.
172. Cheville AL, McGarvey CL, Petrek JA, et al. Lymphedema management. Semin Radiat Oncol 2003;13:290-301.
173. Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 2006;13:491-500.
174. Graham PH. Compression prophylaxis may increase the potential for flight-associated lymphoedema after breast cancer treatment. Breast 2002;11:66-71.
175. Paskett ED, Dean JA, Oliveri JM, et al. Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review. J Clin Oncol 2012;30:3726-3733.
176. Badger CM, Peacock JL, Mortimer PS. A randomized, controlled, parallel-group clinical trial comparing multilayer bandaging followed by hosiery versus hosiery alone in the treatment of patients with lymphedema of the limb. Cancer 2000;88:2832-2837.
177. Carati CJ, Anderson SN, Gannon BJ, et al. Treatment of postmastectomy lymphedema with low-level laser therapy: a double blind, placebo-controlled trial. Cancer 2003;98:1114-1122.
178. Ahmed Omar MT, Abd-El-Gayed Ebid A, El Morsy AM. Treatment of post-mastectomy lymphedema with laser therapy: double blind placebo control randomized study. J Surg Res 2011;165:82-90.
179. Loprinzi CL, Kugler JW, Sloan JA, et al. Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. N Engl J Med 1999;340:346-350.
180. Pecking AP, Fevrier B, Wargon C, et al. Efficacy of Daflon 500 mg in the treatment of lymphedema (secondary to conventional therapy of breast cancer). Angiology 1997;48:93-98.
181. Mehrara BJ, Zampell JC, Suami H, et al. Surgical management of lymphedema: past, present, and future. Lymphatic Res Biol 2011;9:159-167.
182. Ahmed RL, Thomas W, Yee D, et al. Randomized controlled trial of weight training and lymphedema in breast cancer survivors. J Clin Oncol 2006;24:2765-2772.
183. Sagen A, Karesen R, Risberg MA. Physical activity for the affected limb and arm lymphedema after breast cancer surgery. A prospective, randomized controlled trial with two years follow-up. Acta Oncol 2009;48:1102-1110.
184. Schmitz KH, Ahmed RL, Troxel A, et al. Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med 2009;361:664-673.
185. Schmitz KH, Ahmed RL, Troxel AB, et al. Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA 2010;304:2699-2705.
186. Kwan ML, Cohn JC, Armer JM, et al. Exercise in patients with lymphedema: a systematic review of the contemporary literature. J Cancer Surviv 2011;5:320-336.
187. Knols R, Aaronson NK, Uebelhart D, et al. Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. J Clin Oncol 2005;23:3830-3842.
188. McNeely ML, Campbell KL, Rowe BH, et al. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ 2006;175:34-41.
189. Craft LL, Vaniterson EH, Helenowski IB, et al. Exercise effects on depressive symptoms in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2012;21:3-19.
190. Fong DY, Ho JW, Hui BP, et al. Physical activity for cancer survivors: meta-analysis of randomised controlled trials. BMJ 2012;344:e70.
191. Jones LW, Alfano CM. Exercise-oncology research: past, present, and future. Acta Oncol 2013;52:195-215.
192. Schmitz KH, Courneya KS, Matthews C, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 2010;42:1409-1426.
193. Fairey AS, Courneya KS, Field CJ, et al. Physical exercise and immune system function in cancer survivors: a comprehensive review and future directions. Cancer 2002;94:539-551.
194. Jones LW, Courneya KS, Fairey AS, et al. Effects of an oncologist's recommendation to exercise on self-reported exercise behavior in newly diagnosed breast cancer survivors: a single-blind, randomized controlled trial. Ann Behav Med 2004;28:105-113.
195. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-1638.
196. Johansson K, Ohlsson K, Ingvar C, et al. Factors associated with the development of arm lymphedema following breast cancer treatment: a match pair case-control study. Lymphology 2002;35:59-71.
197. Campos MP, Hassan BJ, Riechelmann R, et al. Cancer-related fatigue: a practical review. Ann Oncol 2011;22:1273-1279.
198. Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 2012;11:CD006145.
199. Minton O, Richardson A, Sharpe M, et al. Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis. J Pain Symptom Manage 2011;41:761-767.
200. Allen RJ. Physical agents used in the management of chronic pain by physical therapists. Phys Med Rehabil Clin N Am 2006;17:315-345.
201. Sicard-Rosenbaum L, Danoff J. Cancer and ultrasound: a warning. Phys Ther 1993;73:404-406.
202. Sicard-Rosenbaum L, Lord D, Danoff JV, et al. Effects of continuous therapeutic ultrasound on growth and metastasis of subcutaneous murine tumors. Phys Ther 1995;75:3-11.
203. Sicard-Rosenbaum L, Danoff JV, Guthrie JA, et al. Effects of energy-matched pulsed and continuous ultrasound on tumor growth in mice. Phys Ther 1998;78:271-277.
204. Robertson VJ, Ward AR. Dangers in extrapolating in vitro uses of therapeutic ultrasound. Phys Ther 1996;76:78-79.
205. Chapman BL, Liebert RB, Lininger MR, et al. An introduction to physical therapy modalities. Adolesc Med State Art Rev 2007;18:11-23.
206. Carroll D, Moore RA, McQuay HJ, et al. Transcutaneous electrical nerve stimulation (TENS) for chronic pain. Cochrane Database Syst Rev 2001:CD003222.
207. Walsh DM, Howe TE, Johnson MI, et al. Transcutaneous electrical nerve stimulation for acute pain. Cochrane Database Syst Rev 2009:CD006142.
208. Robb K, Oxberry SG, Bennett MI, et al. A cochrane systematic review of transcutaneous electrical nerve stimulation for cancer pain. J Pain Symptom Manage 2009;37:746-753.
209. Cheville AL. Pain management in cancer rehabilitation. Arch Phys Med Rehabil 2001;82:S84-S87.
210. Nicolson SE, Caplan JP, Williams DE, et al. Comorbid pain, depression, and anxiety: multifaceted pathology allows for multifaceted treatment. Harv Rev Psychiatry 2009;17:407-420.
211. Tang MF, Liou TH, Lin CC. Improving sleep quality for cancer patients: benefits of a home-based exercise intervention. Support Care Cancer 2009;18:1329-1339.
212. Aggarwal VR, Tickle M, Javidi H, et al. Reviewing the evidence: can cognitive behavioral therapy improve outcomes for patients with chronic orofacial pain? J Orofac Pain 2010;24:163-171.
213. Griffith K, Wenzel J, Shang J, et al. Impact of a walking intervention on cardiorespiratory fitness, self-reported physical function, and pain in patients undergoing treatment for solid tumors. Cancer 2009;115:4874-4884.
214. Scott NA, Guo B, Barton PM, et al. Trigger point injections for chronic non-malignant musculoskeletal pain: a systematic review. Pain Med 2009;10:54-69.
215. Bannuru RR, Natov NS, Obadan IE, et al. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Arthritis Rheum 2009;61:1704-1711.
216. Deng G, Cassileth BR, Yeung KS. Complementary therapies for cancer-related symptoms. J Support Oncol 2004;2:419-426.
217. Cassileth BR, Deng G. Complementary and alternative therapies for cancer. Oncologist 2004;9:80-89.